Simplex Trading
BXRX

Simplex Trading’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Simplex Trading’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Hold
0
– -$5K – 11004
2021
Q1 		– Hold
0
– – – 8239
2020
Q4 		– Hold
0
– – – 8201
2020
Q3 		– Hold
0
– -$62K – 8828
2020
Q2 		– Hold
0
– – – 5304
2020
Q1 		– Hold
0
– – – 5455

Other funds holding BXRX

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Simplex Trading's BXRX Position: Q1 2022 in Review

Simplex Trading sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q1 2022, closing a stake of 1 share.

Simplex Trading first reported a position in BXRX in Q1 2020 and held it in 5 quarters. The position peaked at $25K in Q1 2020. 19 funds tracked by Wall St. Rank hold BXRX as of Q1 2022.

  • Simplex Trading reported no remaining Baudax Bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Simplex Trading sold 1 Baudax Bio, Inc. Common Stock share in Q1 2022.
  • Simplex Trading first reported a position in Baudax Bio, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
  • Simplex Trading's Baudax Bio, Inc. Common Stock position peaked at $25K in Q1 2020.
  • 19 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q1 2022.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.